Darrell Hulisz

767 total citations
20 papers, 579 citations indexed

About

Darrell Hulisz is a scholar working on Pharmacology, Epidemiology and Pharmacology. According to data from OpenAlex, Darrell Hulisz has authored 20 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Darrell Hulisz's work include Poisoning and overdose treatments (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Darrell Hulisz is often cited by papers focused on Poisoning and overdose treatments (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Darrell Hulisz collaborates with scholars based in United States. Darrell Hulisz's co-authors include Michael T. Hagley, Thomas M. File, Edward A. Hartshorn, Colleen Burns, Darell Heiselman, B R Martin, R.Daniel Murray, M Bonfiglio, James A. Bobula and Richard L. Brown and has published in prestigious journals such as Infection Control and Hospital Epidemiology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Darrell Hulisz

20 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darrell Hulisz United States 13 147 117 73 70 70 20 579
Y Zopf Germany 15 86 0.6× 185 1.6× 79 1.1× 139 2.0× 60 0.9× 22 833
Pui Kuan Cheong Hong Kong 13 195 1.3× 165 1.4× 92 1.3× 138 2.0× 50 0.7× 27 680
John M. Weller United States 20 75 0.5× 130 1.1× 57 0.8× 120 1.7× 27 0.4× 54 986
Masaki Sanaka Japan 16 304 2.1× 322 2.8× 84 1.2× 60 0.9× 28 0.4× 60 885
Foster United Kingdom 8 127 0.9× 167 1.4× 48 0.7× 76 1.1× 36 0.5× 15 538
Yasushi Kuyama Japan 16 324 2.2× 320 2.7× 66 0.9× 50 0.7× 41 0.6× 76 875
J M Segrestaa France 9 46 0.3× 97 0.8× 42 0.6× 19 0.3× 11 0.2× 24 458
Michael R. Uhing United States 19 21 0.1× 282 2.4× 143 2.0× 78 1.1× 40 0.6× 51 922
William A. Edwards United States 11 21 0.1× 154 1.3× 75 1.0× 41 0.6× 29 0.4× 16 579

Countries citing papers authored by Darrell Hulisz

Since Specialization
Citations

This map shows the geographic impact of Darrell Hulisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darrell Hulisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darrell Hulisz more than expected).

Fields of papers citing papers by Darrell Hulisz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darrell Hulisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darrell Hulisz. The network helps show where Darrell Hulisz may publish in the future.

Co-authorship network of co-authors of Darrell Hulisz

This figure shows the co-authorship network connecting the top 25 collaborators of Darrell Hulisz. A scholar is included among the top collaborators of Darrell Hulisz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darrell Hulisz. Darrell Hulisz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hulisz, Darrell. (2018). Amyotrophic lateral sclerosis: disease state overview.. PubMed. 24(15 Suppl). S320–S326. 69 indexed citations
2.
Hulisz, Darrell. (2015). Updated Beers Criteria: A more comprehensive guide to medication safety in older adults. Pharmacy Today. 21(11). 39–40. 1 indexed citations
3.
Brown, Richard L., et al.. (2007). Pharmacoepidemiology of potential alcohol–prescription drug interactions among primary care patients with alcohol-use disorders. Journal of the American Pharmacists Association. 47(2). 135–139. 13 indexed citations
4.
Bonder, Bette, et al.. (2006). Community-Based Substance Abuse Training. Substance Abuse. 26(3-4). 27–30. 1 indexed citations
5.
Hulisz, Darrell. (2004). The Burden of Illness of Irritable Bowel Syndrome: Current Challenges and Hope for the Future. Journal of Managed Care Pharmacy. 10(4). 299–309. 170 indexed citations
6.
Hulisz, Darrell. (2004). Efficacy of Zinc Against Common Cold Viruses: An Overview. Journal of the American Pharmacists Association. 44(5). 594–603. 75 indexed citations
7.
Hulisz, Darrell, et al.. (1998). Metformin-Associated Lactic Acidosis. The Journal of the American Board of Family Medicine. 11(3). 233–236. 15 indexed citations
8.
Hulisz, Darrell, et al.. (1995). Thrombocytopenia in Intensive Care Patients: A Comprehensive Analysis of Risk Factors in 314 Patients. Annals of Pharmacotherapy. 29(9). 835–842. 69 indexed citations
9.
Hulisz, Darrell, et al.. (1994). Complete Heart Block and Torsade de Pointes Associated With Thioridazine Poisoning. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(2). 239–245. 20 indexed citations
10.
Hulisz, Darrell, et al.. (1993). Sinus Arrest Associated With Continuous‐Infusion Cimetidine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(1). 64–67. 4 indexed citations
11.
Hulisz, Darrell, et al.. (1993). Clinical Review of Canthaxanthin (6Tanning Pills’). American Pharmacy. 33(8). 44–46. 5 indexed citations
12.
Hagley, Michael T. & Darrell Hulisz. (1993). Authors' Reply. Annals of Pharmacotherapy. 27(9). 1142–1143. 2 indexed citations
13.
Hagley, Michael T., Darrell Hulisz, Colleen Burns, & Edward A. Hartshorn. (1993). Hepatotoxicity Associated with Angiotensin-Converting Enzyme Inhibitors. Annals of Pharmacotherapy. 27(2). 228–231. 42 indexed citations
14.
Hulisz, Darrell & Thomas M. File. (1992). Predisposing Factors and Antibiotic Use in Nosocomial Infections Caused by Xanthomonas maltophilia. Infection Control and Hospital Epidemiology. 13(8). 489–490. 21 indexed citations
15.
Hagley, Michael T., et al.. (1992). Hemolytic-Uremic Syndrome Associated with Ingestion of Quinine. American Journal of Nephrology. 12(3). 192–195. 15 indexed citations
16.
Bonfiglio, M, et al.. (1992). Anaphylactoid Reaction to Intravenous Acetylcysteine Associated with Electrocardiographic Abnormalities. Annals of Pharmacotherapy. 26(1). 22–25. 18 indexed citations
17.
Hagley, Michael T., et al.. (1992). Suspected Cross-Reactivity of Enalapril- and Captopril-Induced Hepatotoxicity. Annals of Pharmacotherapy. 26(6). 780–781. 18 indexed citations
18.
Hulisz, Darrell & Thomas M. File. (1992). Predisposing Factors and Antibiotic Use in Nosocomial Infections Caused by Xanthomonas maltophilia. Infection Control and Hospital Epidemiology. 13(8). 489–490. 15 indexed citations
19.
Hulisz, Darrell, et al.. (1991). Study of Antipsychotic Drug Use in Long-Term Care Facilities. Journal of Pharmacy Technology. 7(1). 13–18. 1 indexed citations
20.
Hulisz, Darrell, et al.. (1990). Update on Quinolone Drug Interactions. American Pharmacy. 30(9). 34–36. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026